Reading IONQ? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track IONQ free→Reading IONQ? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track IONQ free→QuarterlyIQ Insights · IONQ
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
Results of Operations and Financial Condition. On May 6, 2026, IonQ, Inc. (the “ Company ”) issued a press release announcing its financial results for the first quarter ended March 31, 2026. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information provided in this Form 8-K, including Exhibit 99.1 hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On March 19, 2026, the Board of Directors (the “ Board ”) of IonQ, Inc., a Delaware corporation (the “ Company ”), on the recommendation of the Nominating and Corporate Governance Committee of the Board, added a seat to the Board and elected William F. Scannell, age 63, to the resulting vacancy, effective March 20, 2026. The vacancy to which Mr. Sc…
Unregistered Sales of Equity Securities. On March 11, 2026, IonQ, Inc. (the “Company”) filed with the Securities and Exchange Commission (the “SEC”) a prospectus supplement to the prospectus included in the Company’s Registration Statement on Form S-3ASR filed with the SEC on February 26, 2025 (File No. 333-285279) (the “Registration Statement”), covering the resale by the selling stockholder of an aggregate of 2,562,642 shares of Company common stock, par value $0.0001 per share. The prospec…
Other Events. On February 27, 2026, IonQ, Inc. (the “Company”) filed with the Securities and Exchange Commission (the “SEC”) a prospectus supplement to the prospectus included in the Company’s registration statement on Form S-3ASR filed with the SEC on February 26, 2025 (File No. 333-285279) (the “Registration Statement”), covering the resale by certain selling stockholders of an aggregate of 5,127,459 shares of Company common stock, par value $0.0001 per share. A copy of the legal opinion of…
Results of Operations and Financial Condition. On February 25, 2026, IonQ, Inc. (the “ Company ”) issued a press release announcing its financial results for the fourth quarter ended December 31, 2025. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information provided in this Form 8-K, including Exhibit 99.1 hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of…
The issuance of shares of common stock of the Company, par value $0.0001 per share (each, a “ Company Share ”) in connection with the transaction was made in reliance on the private offering exemption of Section 4(a)(2) of the Securities Act of 1933, as amended (the “ Securities Ac t”), and/or the private offering provision of Rule 506 of Regulation D and was not previously reported in reliance on Item 3.02(b) of Form 8-K. Skyloom Global Acquisition On January 26, 2026, the Company completed…
of this Form 8-K, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act ”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any of the Company’s filings under the Securities Act of 1933, as amended (the “ Securities Act ”), or the Exchange Act, except as expressly set forth by specific reference in such filing.
Entry into a Material Definitive Agreement. Agreement and Plan of Merger On January 25, 2026, IonQ, Inc., a Delaware corporation (the “ Company ”), SkyWater Technology, Inc., a Delaware corporation (“ SkyWater ”), Iris Merger Subsidiary 1 Inc., a Delaware corporation (“ Merger Sub 1 ”), and Iris Merger Subsidiary 2 LLC, a Delaware limited liability company (“ Merger Sub 2 ” and, together with Merger Sub 1, the “ Merger Subs ”), entered into an Agreement and Plan of Merger (the “ Merger Agreem…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Kramer Separation As a result of his departure, Mr. Kramer will qualify for certain benefits under the Company’s Amended and Restated Executive Severance Plan (the “ Executive Severance Plan ”) and his performance-based restricted stock unit (“ PSU ”) award agreement (the “ PSU Award Agreement ”). Accordingly, on December 2, 2025, the Company and M…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Alameddine Separation On November 17, 2025, IonQ, Inc. (the “ Company ”) and Rima Alameddine determined that her last day as Chief Revenue Officer of the Company would be November 24, 2025. As a result of her departure, Ms. Alameddine will qualify for certain benefits under the Company’s Amended and Restated Executive Severance Plan (the “ Executiv…
Other Events. On November 10, 2025, IonQ, Inc. (the “Company”) filed with the Securities and Exchange Commission (the “SEC”) a prospectus supplement to the prospectus included in the Company’s registration statement on Form S-3ASR filed with the SEC on February 26, 2025 (File No. 333-285279) (the “Registration Statement”), covering the resale by the selling stockholder of an aggregate of 2,108,993 shares of Company common stock, par value $0.0001 per share. The prospectus supplement was filed…
Results of Operations and Financial Condition. On November 5, 2025, IonQ, Inc. (the “ Company ”) issued a press release announcing its financial results for the third quarter ended September 30, 2025. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information provided in this Form 8-K, including Exhibit 99.1 hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of…
Other Events. On October 16, 2025, IonQ, Inc. (the “Company”) filed with the Securities and Exchange Commission (the “SEC”) a prospectus supplement to the prospectus included in the Company’s registration statement on Form S-3ASR filed with the SEC on February 26, 2025 (File No. 333-285279) (the “Registration Statement”), covering the resale by certain selling stockholders of an aggregate of 6,649,263 shares of Company common stock, par value $0.0001 per share. A copy of the legal opinion of…
Other Events. On October 16, 2025, IonQ, Inc. (the “Company”) filed with the Securities and Exchange Commission (the “SEC”) a prospectus supplement to the prospectus included in the Company’s registration statement on Form S-3ASR filed with the SEC on February 26, 2025 (File No. 333-285279) (the “Registration Statement”), covering the resale by certain selling stockholders of an aggregate of 25,275,276 shares of Company common stock, par value $0.0001 per share. A copy of the legal opinion of…
Departures of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Bill Scannell’s resignation from the Board and his concurrent assumption of the role of Senior Commercial Advisor, which was previously disclosed as being expected in connection with the appointment of General John W. Raymond to the Board, occurred on October 1, 2025.
The issuance and sale of shares of IonQ, Inc. (the “ Company ”) common stock in connection with the Transaction (as defined below) was made in reliance on the private offering exemption of Section 4(a)(2) of the Securities Act of 1933, as amended (the “ Securities Act ”), and/or the private offering provision of Rule 506 of Regulation D.
Departures of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Appointment of New Director On September 25, 2025, the Board of Directors (the “ Board ”) of IonQ, Inc. (the “ Company ”), following the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed John W. Raymond to serve as a member of the Board, effective immediately. General Raymond was appointed as a Class I dir…
The issuance and sale of shares of IonQ, Inc. (the “ Company ”) common stock in connection with the Oxford Ionics Transaction (as defined below) was made in reliance on the private offering exemption of Section 4(a)(2) of the Securities Act of 1933, as amended (the “ Securities Act ”), and/or the private offering provision of Rule 506 of Regulation D and/or Regulation S promulgated under the Securities Act. The issuance and sale of shares of Company common stock in connection with the Vector…
Departures of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Executive Transition On September 2, 2025, the board of directors (the “ Board ”) of IonQ, Inc. (the “ Company ”) appointed Inder M. Singh, the Lead Independent Director of the Board, to the positions of Chief Financial Officer (“ CFO ”) and Chief Operating Officer (“ COO ”) effective as of September 4, 2025 (the “ Transition Date ”), succeeding T…
Departures of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Appointment of New Directors On August 26, 2025, the Board of Directors (the “ Board ”) of IonQ, Inc. (the “ Company ”), following the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Jim Frankola and William J. Teuber, Jr. to serve as members of the Board, effective immediately. Mr. Frankola was appointe…
Other Events. On August 28, 2025, IonQ, Inc. (the “Company”) filed with the Securities and Exchange Commission (the “SEC”) a prospectus supplement to the prospectus included in the Company’s registration statement on Form S-3ASR filed with the SEC on February 26, 2025 (File No. 333-285279) (the “Registration Statement”), covering the resale by certain selling stockholders of an aggregate of 12,377,433 shares of Company common stock, par value $0.0001 per share. A copy of the legal opinion of…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Certain Executive Officer Equity Grants The Compensation Committee (the “ Committee ”) of the Board of Directors (the “ Board ”) of IonQ, Inc. (the “ Company ”), together with the Board, periodically reviews the compensation of the Company’s executive officers. On August 11, 2025, the independent members of the Board approved a grant of restricted…
Other Events. On August 11, 2025, IonQ, Inc. (the “Company”) filed with the Securities and Exchange Commission (the “SEC”) a prospectus supplement to the prospectus included in the Company’s registration statement on Form S-3ASR filed with the SEC on February 26, 2025 (File No. 333-285279) (the “Registration Statement”), covering the resale by certain selling stockholders of an aggregate of 13,220,367 shares of Company common stock, par value $0.0001 per share. A copy of the legal opinion of…
Results of Operations and Financial Condition. On August 6, 2025, IonQ, Inc. (the “ Company ”) issued a press release announcing its financial results for the second quarter ended June 30, 2025. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information provided in this Form 8-K, including Exhibit 99.1 hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934,…
Departures of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Appointment of Chairman of the Board; Transition of Former Executive Chairman to Director On August 1, 2025, the board of directors (the “ Board ”) of IonQ, Inc. (the “ Company ”) appointed Niccolo de Masi, the Company’s Chief Executive Officer, to the additional position of Chairman of the Board, succeeding Peter Chapman, who held the role of Exe…
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.